These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 32326783)
1. The role of the triggering receptor expressed on myeloid cells-1 (TREM-1) in non-bacterial infections. de Oliveira Matos A; Dos Santos Dantas PH; Figueira Marques Silva-Sales M; Sales-Campos H Crit Rev Microbiol; 2020 May; 46(3):237-252. PubMed ID: 32326783 [TBL] [Abstract][Full Text] [Related]
2. TREM-1 isoforms in bacterial infections: to immune modulation and beyond. Matos AO; Dantas PHDS; Silva-Sales M; Sales-Campos H Crit Rev Microbiol; 2021 May; 47(3):290-306. PubMed ID: 33522328 [TBL] [Abstract][Full Text] [Related]
3. Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a potential biomarker for the diagnosis of infectious diseases. Cao C; Gu J; Zhang J Front Med; 2017 Jun; 11(2):169-177. PubMed ID: 28425045 [TBL] [Abstract][Full Text] [Related]
4. Triggering receptor expressed on myeloid cells-1 (TREM-1) as a therapeutic target in infectious and noninfectious disease: a critical review. Dantas PHDS; Matos AO; da Silva Filho E; Silva-Sales M; Sales-Campos H Int Rev Immunol; 2020; 39(4):188-202. PubMed ID: 32379561 [TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 4 plays an important role to enhance bacterial clearance from the nose in synergy with triggering receptor expressed on myeloid cells (TREM)-1 expression on polymorphonuclear neutrophils. Moriyama M; Hirano T; Kawano T; Kadowaki Y; Kodama S; Suzuki M Int J Pediatr Otorhinolaryngol; 2018 Sep; 112():27-33. PubMed ID: 30055735 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic Potential of Targeting TREM-1 in Inflammatory Diseases and Cancer. Bosco MC; Raggi F; Varesio L Curr Pharm Des; 2016; 22(41):6209-6233. PubMed ID: 27568730 [TBL] [Abstract][Full Text] [Related]
7. Soluble Triggering Receptor Expressed on Myeloid Cells-1: Diagnosis or Prognosis? Lemarié J; Gibot S Crit Care Clin; 2020 Jan; 36(1):41-54. PubMed ID: 31733681 [TBL] [Abstract][Full Text] [Related]
8. Triggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity? Roe K; Gibot S; Verma S Front Microbiol; 2014; 5():627. PubMed ID: 25505454 [TBL] [Abstract][Full Text] [Related]
9. TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives. Tammaro A; Derive M; Gibot S; Leemans JC; Florquin S; Dessing MC Pharmacol Ther; 2017 Sep; 177():81-95. PubMed ID: 28245991 [TBL] [Abstract][Full Text] [Related]
10. Triggering receptor expressed on myeloid cells 1 (TREM-1) and cytokine gene variants in complicated and uncomplicated malaria. Adukpo S; Gyan BA; Ofori MF; Dodoo D; Velavan TP; Meyer CG Trop Med Int Health; 2016 Dec; 21(12):1592-1601. PubMed ID: 27671831 [TBL] [Abstract][Full Text] [Related]
11. TREM-2: friend or foe in infectious diseases? Matos AO; Dantas PHDS; Queiroz HAGB; Silva-Sales M; Sales-Campos H Crit Rev Microbiol; 2024 Feb; 50(1):1-19. PubMed ID: 36403150 [TBL] [Abstract][Full Text] [Related]
12. An Antibody Against Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) Dampens Proinflammatory Cytokine Secretion by Lamina Propria Cells from Patients with IBD. Brynjolfsson SF; Magnusson MK; Kong PL; Jensen T; Kuijper JL; Håkansson K; Read CB; Stennicke VW; Sjövall H; Jo Wick M Inflamm Bowel Dis; 2016 Aug; 22(8):1803-11. PubMed ID: 27243593 [TBL] [Abstract][Full Text] [Related]
13. The Triggering Receptor Expressed on Myeloid cells-1: A new player during acute myocardial infarction. Jérémie L; Amir B; Marc D; Sébastien G Pharmacol Res; 2015 Oct; 100():261-5. PubMed ID: 26318764 [TBL] [Abstract][Full Text] [Related]
14. Triggering receptor expressed on myeloid cells in the pathogenesis of periodontitis: potential novel treatment strategies. Rudick CP; Miyamoto T; Lang MS; Agrawal DK Expert Rev Clin Immunol; 2017 Dec; 13(12):1189-1197. PubMed ID: 29027827 [TBL] [Abstract][Full Text] [Related]
16. HIV and HCV augments inflammatory responses through increased TREM-1 expression and signaling in Kupffer and Myeloid cells. Hyun J; McMahon RS; Lang AL; Edwards JS; Badilla AD; Greene ME; Stone GW; Pallikkuth S; Stevenson M; Dykxhoorn DM; Kottilil S; Pahwa S; Thomas E PLoS Pathog; 2019 Jul; 15(7):e1007883. PubMed ID: 31260499 [TBL] [Abstract][Full Text] [Related]
17. Effects of BTK signalling in pathogenic microorganism infections. Ye B; Zhou C; Guo H; Zheng M J Cell Mol Med; 2019 Oct; 23(10):6522-6529. PubMed ID: 31397086 [TBL] [Abstract][Full Text] [Related]
18. Assessment of Serum sTREM-1 as a Marker of Subclinical Inflammation in Diarrhea-Predominant Patients with Irritable Bowel Syndrome. Du C; Peng L; Kou G; Wang P; Lu L; Li Y Dig Dis Sci; 2018 May; 63(5):1182-1191. PubMed ID: 29516326 [TBL] [Abstract][Full Text] [Related]
19. Role of triggering receptor expressed on myeloid cells-1 (TREM-1) in COVID-19 and other viral pneumonias: a systematic review and meta-analysis of clinical studies. de Oliveira YLM; de Sá Resende A; Martins-Filho PR; de Moura TR Inflammopharmacology; 2022 Jun; 30(3):1037-1045. PubMed ID: 35347523 [TBL] [Abstract][Full Text] [Related]
20. From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Sharif O; Knapp S Immunobiology; 2008; 213(9-10):701-13. PubMed ID: 18926286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]